Bella Oguno, MPH
Vice President, Development Operations Nuvig Therapeutics
Redwood City, California
Bella Oguno is the Vice President of Development Operations at Nuvig Therapeutics, where she supports their global clinical development programs. She has more than 20 years of experience in clinical operations, developing operational strategies for multiple global and complex clinical trials. Her current focus is in rare diseases, previously she supported programs in oncology and the cardiorenal space.
Prior to Nuvig, she worked at Global Blood Therapeutics (GBT), where she oversaw the execution of their sickle cell programs across multiple studies with clinical sites in North America, the European Union, Africa, the Middle East and Latin America. Prior to GBT, she held various leadership positions at Genentech and Amgen where she supported the execution of global development programs. Bella holds a BA in Sociology, Health Care and Social Issues from UC San Diego and an MPH from Benedictine University.